Makers Laboratories Ltd. (BSE: 506919) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹122 Cr, it ranks #3,103 by market cap among the 6,137 Indian listed companies on FinBizNet, and #40 of 63 in Pharmaceuticals. At ₹187.02 (as of 25 Oct 2026), the share price is 20.8% below its 52-week high of ₹236.00 and 24.7% above its 52-week low of ₹150.00. The share price is up 27.7% over one year and up 24.6% over three months.
| Current Price | ₹187.02 |
|---|---|
| Market Cap | ₹122 Cr |
| BSE Code | 506919 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 53.3 |
| Return on Equity | 9.94% |
| Return on Assets | 4.15% |
| 52-Week Range | ₹150.00 – ₹236.00 |
| 1-Year Price Change | +27.7% |
| 3-Month Price Change | +24.6% |
| Beta (1Y) | 0.2 |
| Dividend Yield | 0.00% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.makerslabs.com |
Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialty drugs. The company sells its products under the Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin brands. It distributes its products through agents, stockiest, doctors, and retailers. The company was incorporated in 1984 and is based in Mumbai, India.
1. Pharmaceutical-This segment offers pharmaceutical products. 2. Chemical Manufacturing-This segment engages in the chemical manufacturing business. 3. Segment Adjustment-0
1. Pharmaceutical-35.8% 2. Chemical Manufacturing-64.2%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹55,577 Cr | 35.5 | 34.46% | ₹1,814 Cr | -16.1% |
| Ajanta Pharma Limited | ₹41,591 Cr | 39 | 25.39% | ₹1,626 Cr | +36.3% |
| Emcure Pharmaceuticals Ltd | ₹34,533 Cr | 36.3 | 19.57% | ₹2,580 Cr | +31.1% |
| Piramal Pharma Ltd | ₹26,284 Cr | -79 | -4.00% | ₹2,270 Cr | -1.6% |
| RUBICON RESEARCH LIMITED | ₹24,972 Cr | 97.6 | 19.14% | ₹534 Cr | — |
| Caplin Point Laboratories Ltdte | ₹17,484 Cr | 26.9 | 19.94% | ₹610 Cr | +10.3% |
| Pfizer Ltd. | ₹17,448 Cr | 24.1 | 17.16% | ₹653 Cr | -32.1% |
| Eris Lifesciences Ltd | ₹15,877 Cr | 24.8 | 18.07% | ₹873 Cr | -30.8% |
| Makers Laboratories Ltd. | ₹122 Cr | 53.3 | 9.94% | — | +27.7% |
Listed by market capitalisation. Ratios are shown for context only.
Makers Laboratories Ltd. is trading at ₹187.02, with a market capitalisation of ₹122 Cr.
Makers Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Makers Laboratories Ltd. has a P/E of 53.3 and a return on equity of 9.94%.
Makers Laboratories Ltd. is listed on the BSE under the scrip code 506919.
Makers Laboratories Ltd.'s share price is up 27.7% over one year and up 24.6% over three months. Its 52-week range is ₹150.00 to ₹236.00.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.